BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, Putignani L, Fischer M, Keller JJ, Costello SP, Sokol H, Kump P, Satokari R, Kahn SA, Kao D, Arkkila P, Kuijper EJ, Vehreschild MJG, Pintus C, Lopetuso L, Masucci L, Scaldaferri F, Terveer EM, Nieuwdorp M, López-Sanromán A, Kupcinskas J, Hart A, Tilg H, Gasbarrini A. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut 2019;68:2111-21. [PMID: 31563878 DOI: 10.1136/gutjnl-2019-319548] [Cited by in Crossref: 160] [Cited by in F6Publishing: 141] [Article Influence: 53.3] [Reference Citation Analysis]
Number Citing Articles
1 Qu Z, Tian P, Yang B, Zhao J, Wang G, Chen W. Fecal microbiota transplantation for diseases: Therapeutic potential, methodology, risk management in clinical practice. Life Sci 2022;304:120719. [PMID: 35716734 DOI: 10.1016/j.lfs.2022.120719] [Reference Citation Analysis]
2 Kelly CR, Laine LA, Wu GD. Monitoring Fecal Microbiota Transplantation Practice in a Rapidly Evolving Health and Regulatory Environment. Gastroenterology 2020;159:2004-6. [PMID: 32841646 DOI: 10.1053/j.gastro.2020.08.039] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nooij S, Ducarmon QR, Laros JFJ, Zwittink RD, Norman JM, Smits WK, Verspaget HW, Keller JJ, Terveer EM, Kuijper EJ; Working Group of the Netherlands Donor Feces Bank. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients. Gastroenterology 2021:S0016-5085(21)03120-6. [PMID: 34126062 DOI: 10.1053/j.gastro.2021.06.009] [Reference Citation Analysis]
4 Chapman PR, Giacomin P, Loukas A, McCarthy JS. Experimental human hookworm infection: a narrative historical review. PLoS Negl Trop Dis 2021;15:e0009908. [PMID: 34882670 DOI: 10.1371/journal.pntd.0009908] [Reference Citation Analysis]
5 Jouhten H, Ronkainen A, Aakko J, Salminen S, Mattila E, Arkkila P, Satokari R. Cultivation and Genomics Prove Long-Term Colonization of Donor's Bifidobacteria in Recurrent Clostridioides difficile Patients Treated With Fecal Microbiota Transplantation. Front Microbiol 2020;11:1663. [PMID: 32760391 DOI: 10.3389/fmicb.2020.01663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Larussa T, Abenavoli L, Fabiano G, Mancuso MA, Polimeni N, Dumitrascu DL, Luzza F. Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. Minerva Gastroenterol 2021;67. [DOI: 10.23736/s2724-5985.21.02907-7] [Reference Citation Analysis]
7 Aràjol C, Aira Gómez A, González-Suárez B, Casals-Pascual C, Martí Martí S, Domínguez Luzón MÁ, Soriano A, Guardiola Capón J; en representación del Grupo Catalán para el Estudio y Desarrollo de la Transferencia de Microbiota Fecal. Donor selection for faecal microbiota transplantation. Consensus document of the Catalan Society of Gastroenterology and the Catalan Society of Infectious Diseases and Clinical Microbiology. Gastroenterol Hepatol 2021;44:175-80. [PMID: 33309073 DOI: 10.1016/j.gastrohep.2020.07.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bibbò S, Settanni CR, Porcari S, Bocchino E, Ianiro G, Cammarota G, Gasbarrini A. Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor. J Clin Med 2020;9:E1757. [PMID: 32517023 DOI: 10.3390/jcm9061757] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
9 Sood A, Singh A, Mahajan R, Midha V, Kaur K, Singh D, Bansal N, Dharni K. Clinical Predictors of response to Faecal Microbiota Transplantation in patients with active ulcerative colitis. J Crohns Colitis 2020:jjaa163. [PMID: 32772093 DOI: 10.1093/ecco-jcc/jjaa163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Benech N, Leboucher G, Monard C, Ferry T. Septic shock due to refractory severe clostridioides difficile colitis rapidly resolving after faecal microbiota transplantation. BMJ Case Rep 2020;13:e234329. [PMID: 32900719 DOI: 10.1136/bcr-2020-234329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Deschamps C, Fournier E, Uriot O, Lajoie F, Verdier C, Comtet-Marre S, Thomas M, Kapel N, Cherbuy C, Alric M, Almeida M, Etienne-Mesmin L, Blanquet-Diot S. Comparative methods for fecal sample storage to preserve gut microbial structure and function in an in vitro model of the human colon. Appl Microbiol Biotechnol 2020;104:10233-47. [PMID: 33085024 DOI: 10.1007/s00253-020-10959-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Kazemian N, Kao D, Pakpour S. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic. Int J Mol Sci 2021;22:3004. [PMID: 33809421 DOI: 10.3390/ijms22063004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Olesen SW, Zaman A, Osman M, Ramakrishna B. Modeling Donor Screening Strategies to Reduce the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission via Fecal Microbiota Transplantation. Open Forum Infect Dis 2020;7:ofaa499. [PMID: 33235890 DOI: 10.1093/ofid/ofaa499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zellmer C, Sater MRA, Huntley MH, Osman M, Olesen SW, Ramakrishna B. Shiga Toxin–Producing Escherichia coli Transmission via Fecal Microbiota Transplant. Clinical Infectious Diseases 2021;72:e876-80. [DOI: 10.1093/cid/ciaa1486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
15 Ianiro G, Mullish BH, Kelly CR, Sokol H, Kassam Z, Ng S, Fischer M, Allegretti JR, Masucci L, Zhang F, Keller J, Sanguinetti M, Costello SP, Tilg H, Gasbarrini A, Cammarota G. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020;5:430-432. [PMID: 32192627 DOI: 10.1016/s2468-1253(20)30082-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 44] [Article Influence: 33.5] [Reference Citation Analysis]
16 Wang Y, Xu L, Sun X, Wan X, Sun G, Jiang R, Li W, Tian Y, Liu X, Kang X. Characteristics of the fecal microbiota of high- and low-yield hens and effects of fecal microbiota transplantation on egg production performance. Res Vet Sci 2020;129:164-73. [PMID: 32036124 DOI: 10.1016/j.rvsc.2020.01.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Olesen SW. Power calculations for detecting differences in efficacy of fecal microbiota donors. Contemp Clin Trials Commun 2020;20:100674. [PMID: 33241161 DOI: 10.1016/j.conctc.2020.100674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Hartuis S, Lavergne RA, Nourrisson C, Verweij J, Desoubeaux G, Lussac-Sorton F, Lemoine JP, Cateau E, Jeddi F, Poirier P, Le Pape P, Morio F. The Novodiag® Stool parasites assay, an innovative high-plex technique for fast detection of protozoa, helminths and microsporidia in stool samples: a retrospective and prospective study. Parasite 2022;29:27. [PMID: 35550028 DOI: 10.1051/parasite/2022026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Halaweish HF, Boatman S, Staley C. Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application. Front Cell Infect Microbiol 2022;12:826114. [DOI: 10.3389/fcimb.2022.826114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wang X, Cao Z, Zhang M, Meng L, Ming Z, Liu J. Bioinspired oral delivery of gut microbiota by self-coating with biofilms. Sci Adv 2020;6:eabb1952. [PMID: 32637620 DOI: 10.1126/sciadv.abb1952] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
21 Lin H, Guo Q, Wen Z, Tan S, Chen J, Lin L, Chen P, He J, Wen J, Chen Y. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors. Microb Cell Fact 2021;20:233. [PMID: 34963452 DOI: 10.1186/s12934-021-01720-1] [Reference Citation Analysis]
22 Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol 2021;18:67-80. [PMID: 32843743 DOI: 10.1038/s41575-020-0350-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
23 Cibulková I, Řehořová V, Hajer J, Duška F. Fecal Microbial Transplantation in Critically Ill Patients-Structured Review and Perspectives. Biomolecules 2021;11:1459. [PMID: 34680092 DOI: 10.3390/biom11101459] [Reference Citation Analysis]
24 Kragsnaes MS, Nilsson AC, Kjeldsen J, Holt HM, Rasmussen KF, Georgsen J, Ellingsen T, Holm DK. How do I establish a stool bank for fecal microbiota transplantation within the blood- and tissue transplant service? Transfusion 2020;60:1135-41. [PMID: 32468608 DOI: 10.1111/trf.15816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
25 McCune VL, Quraishi MN, Manzoor S, Moran CE, Banavathi K, Steed H, Massey DCO, Trafford GR, Iqbal TH, Hawkey PM. Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection. EClinicalMedicine 2020;20:100301. [PMID: 32300746 DOI: 10.1016/j.eclinm.2020.100301] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
26 Ianiro G, Segal JP, Mullish BH, Quraishi MN, Porcari S, Fabiani G, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders. Future Microbiol 2020;15:1173-83. [PMID: 32954843 DOI: 10.2217/fmb-2020-0061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Mehta N, Wang T, Friedman-Moraco RJ, Carpentieri C, Mehta AK, Rouphael N, Dhere T, Larsen CP, Kraft CS, Woodworth MH. Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients. J Clin Microbiol 2021;:JCM0016121. [PMID: 34133889 DOI: 10.1128/JCM.00161-21] [Reference Citation Analysis]
28 Goloshchapov OV, Chukhlovin AB, Bakin EA, Stanevich OV, Klementeva RV, Shcherbakov AA, Shvetsov AN, Suvorova MA, Bondarenko SN, Kucher MA, Kulagin AD, Zubarovskaya LS, Moiseev IS. [Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety]. Ter Arkh 2020;92:43-54. [PMID: 33346444 DOI: 10.26442/00403660.2020.07.000773] [Reference Citation Analysis]
29 Feng J, Tang YN, Zhou LX, Pan JS. Standardized Nursing Procedures for Fecal Microbiota Transplantation via Upper Endoscopy. Gastroenterol Nurs 2021;44:227-32. [PMID: 34176888 DOI: 10.1097/SGA.0000000000000577] [Reference Citation Analysis]
30 Haifer C, Kelly CR, Paramsothy S, Andresen D, Papanicolas LE, McKew GL, Borody TJ, Kamm M, Costello SP, Andrews JM, Begun J, Chan HT, Connor S, Ghaly S, Johnson PD, Lemberg DA, Paramsothy R, Redmond A, Sheorey H, van der Poorten D, Leong RW. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut 2020;69:801-10. [PMID: 32047093 DOI: 10.1136/gutjnl-2019-320260] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
31 Takáčová M, Bomba A, Tóthová C, Micháľová A, Turňa H. Any Future for Faecal Microbiota Transplantation as a Novel Strategy for Gut Microbiota Modulation in Human and Veterinary Medicine? Life 2022;12:723. [DOI: 10.3390/life12050723] [Reference Citation Analysis]
32 Hyde MK, Masser BM. Eligible blood donors' decisions about donating stool for fecal microbiota transplantation: Does ambivalence play a role? Transfusion 2021;61:474-83. [PMID: 33006187 DOI: 10.1111/trf.16109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Rebersek M. Gut microbiome and its role in colorectal cancer. BMC Cancer 2021;21:1325. [PMID: 34895176 DOI: 10.1186/s12885-021-09054-2] [Reference Citation Analysis]
34 Ianiro G, Mullish BH, Hvas CL, Segal JP, Kuijper EJ, Costello SP, Kelly CR, Allegretti JR, Fischer M, Iqbal TH, Satokari R, Kao D, van Prehn J, Ng SC, Bibbò S, Baunwall SMD, Quraishi MN, Sokol H, Zhang F, Keller J, Masucci L, Quaranta G, Kassam Z, Sanguinetti M, Tilg H, Gasbarrini A, Cammarota G. SARS-CoV-2 vaccines and donor recruitment for FMT. Lancet Gastroenterol Hepatol 2021;6:264-6. [PMID: 33571456 DOI: 10.1016/S2468-1253(21)00032-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Mamoon L, Olesen SW. Fecal Microbiota Transplants Annually and Their Positive Clinical Impact. Clin Transl Gastroenterol 2020;11:e00247. [PMID: 33259159 DOI: 10.14309/ctg.0000000000000247] [Reference Citation Analysis]
36 Yau YK, Mak WYJ, Lui NSR, Ng WYR, Cheung CYK, Li YLA, Ching YLJ, Chin ML, Lau HSL, Chan KLF, Chan KSP, Ng SC. High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong. United European Gastroenterol J 2021;9:1027-38. [PMID: 34623758 DOI: 10.1002/ueg2.12160] [Reference Citation Analysis]
37 Cold F, Kousgaard SJ, Halkjaer SI, Petersen AM, Nielsen HL, Thorlacius-Ussing O, Hansen LH. Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis: A Systematic Review. Microorganisms 2020;8:E1433. [PMID: 32962069 DOI: 10.3390/microorganisms8091433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Lu G, Wang W, Li P, Wen Q, Cui B, Zhang F. Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Microb Biotechnol 2022. [PMID: 35576458 DOI: 10.1111/1751-7915.14074] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Keller JJ, Ooijevaar RE, Hvas CL, Terveer EM, Lieberknecht SC, Högenauer C, Arkkila P, Sokol H, Gridnyev O, Mégraud F, Kump PK, Nakov R, Goldenberg SD, Satokari R, Tkatch S, Sanguinetti M, Cammarota G, Dorofeev A, Gubska O, Laniro G, Mattila E, Arasaradnam RP, Sarin SK, Sood A, Putignani L, Alric L, Baunwall SMD, Kupcinskas J, Link A, Goorhuis AG, Verspaget HW, Ponsioen C, Hold GL, Tilg H, Kassam Z, Kuijper EJ, Gasbarrini A, Mulder CJJ, Williams HRT, Vehreschild MJGT. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterol J 2021;9:229-47. [PMID: 33151137 DOI: 10.1177/2050640620967898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
40 Aira A, Rubio E, Fehér C, González-Suárez B, Casals-Pascual C, Soriano Á. Stool donor recruitment - A one-year experience. Enferm Infecc Microbiol Clin (Engl Ed) 2021:S0213-005X(21)00044-6. [PMID: 33712265 DOI: 10.1016/j.eimc.2021.01.018] [Reference Citation Analysis]
41 Yeh YM, Cheng HT, Le PH, Chen CC, Kuo CJ, Chen CL, Chiu CT, Chiu CH. Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome. Biomed J 2021:S2319-4170(21)00067-6. [PMID: 34118466 DOI: 10.1016/j.bj.2021.06.001] [Reference Citation Analysis]
42 Caldeira LF, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis. PLoS One 2020;15:e0238910. [PMID: 32946509 DOI: 10.1371/journal.pone.0238910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
43 Baunwall SMD, Terveer EM, Dahlerup JF, Erikstrup C, Arkkila P, Vehreschild MJ, Ianiro G, Gasbarrini A, Sokol H, Kump PK, Satokari R, De Looze D, Vermeire S, Nakov R, Brezina J, Helms M, Kjeldsen J, Rode AA, Kousgaard SJ, Alric L, Trang-Poisson C, Scanzi J, Link A, Stallmach A, Kupcinskas J, Johnsen PH, Garborg K, Rodríguez ES, Serrander L, Brummer RJ, Galpérine KT, Goldenberg SD, Mullish BH, Williams HR, Iqbal TH, Ponsioen C, Kuijper EJ, Cammarota G, Keller JJ, Hvas CL. The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. Lancet Reg Health Eur 2021;9:100181. [PMID: 34693388 DOI: 10.1016/j.lanepe.2021.100181] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
44 Reygner J, Charrueau C, Delannoy J, Mayeur C, Robert V, Cuinat C, Meylheuc T, Mauras A, Augustin J, Nicolis I, Modoux M, Joly F, Waligora-Dupriet AJ, Thomas M, Kapel N. Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of Clostridioides difficile infection. Gut Microbes 2020;11:1405-22. [PMID: 32501140 DOI: 10.1080/19490976.2020.1759489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
45 Dasharathy SS, Limketkai BN, Sauk JS. What's New in the Postoperative Management of Crohn's Disease? Dig Dis Sci 2021. [PMID: 34406585 DOI: 10.1007/s10620-021-07205-w] [Reference Citation Analysis]
46 Guilfoyle J, Considine J, Bouchoucha SL. Faecal microbiota transplantation and the patient experience: A systematic review. J Clin Nurs 2021;30:1236-52. [PMID: 33377562 DOI: 10.1111/jocn.15625] [Reference Citation Analysis]
47 Zhang X, Tian H, Chen Q, Qin H, Li N. Fecal microbiota transplantation: standardization or diversification? Sci China Life Sci 2019;62:1714-6. [PMID: 31813093 DOI: 10.1007/s11427-019-1592-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Vernocchi P, Del Chierico F, Putignani L. Gut Microbiota Metabolism and Interaction with Food Components. Int J Mol Sci 2020;21:E3688. [PMID: 32456257 DOI: 10.3390/ijms21103688] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
49 Gweon TG, Lee YJ, Kim KO, Yim SK, Soh JS, Kim SY, Park JJ, Shin SY, Lee TH, Choi CH, Cho YS, Yong D, Chung JW, Lee KJ, Lee OY, Choi MG, Choi M; Gut Microbiota and Therapy Research Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea. J Neurogastroenterol Motil 2022;28:28-42. [PMID: 34980687 DOI: 10.5056/jnm21221] [Reference Citation Analysis]
50 Hanssen NMJ, de Vos WM, Nieuwdorp M. Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? Cell Metab 2021;33:1098-110. [PMID: 34077717 DOI: 10.1016/j.cmet.2021.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Herrera G, Paredes-Sabja D, Patarroyo MA, Ramírez JD, Muñoz M. Updating changes in human gut microbial communities associated with Clostridioides difficile infection. Gut Microbes 2021;13:1966277. [PMID: 34486488 DOI: 10.1080/19490976.2021.1966277] [Reference Citation Analysis]
52 Spindelboeck W, Halwachs B, Bayer N, Huber-Krassnitzer B, Schulz E, Uhl B, Gaksch L, Hatzl S, Bachmayr V, Kleissl L, Kump P, Deutsch A, Stary G, Greinix H, Gorkiewicz G, Högenauer C, Neumeister P. Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study. Ther Adv Hematol 2021;12:20406207211058333. [PMID: 34987741 DOI: 10.1177/20406207211058333] [Reference Citation Analysis]
53 Chen J, Zaman A, Ramakrishna B, Olesen SW. Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank. Front Cell Infect Microbiol 2021;11:622949. [PMID: 33937092 DOI: 10.3389/fcimb.2021.622949] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Wargo JA. Modulating gut microbes. Science 2020;369:1302-3. [PMID: 32913089 DOI: 10.1126/science.abc3965] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
55 Tan P, Li X, Shen J, Feng Q. Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update. Front Pharmacol. 2020;11:574533. [PMID: 33041818 DOI: 10.3389/fphar.2020.574533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
56 Brevi A, Cogrossi LL, Grazia G, Masciovecchio D, Impellizzieri D, Lacanfora L, Grioni M, Bellone M. Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer. Front Immunol 2020;11:565470. [PMID: 33244315 DOI: 10.3389/fimmu.2020.565470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
57 Feng W, Liu J, Ao H, Yue S, Peng C. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs. Theranostics 2020;10:11278-301. [PMID: 33042283 DOI: 10.7150/thno.47289] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
58 Saha S, Khanna S. Stool banking for fecal microbiota transplantation: ready for prime time? Hepatobiliary Surg Nutr 2021;10:110-2. [PMID: 33575297 DOI: 10.21037/hbsn-20-371] [Reference Citation Analysis]
59 Junca H, Pieper DH, Medina E. The emerging potential of microbiome transplantation on human health interventions. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
60 Ianiro G, Porcari S, Gasbarrini A, Cammarota G. Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better? Am J Gastroenterol 2021;116:1360-1. [DOI: 10.14309/ajg.0000000000001130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Sehgal K, Khanna S. Gut microbiota: a target for intervention in obesity. Expert Rev Gastroenterol Hepatol 2021;:1-11. [PMID: 34329563 DOI: 10.1080/17474124.2021.1963232] [Reference Citation Analysis]
62 Pane S, Ristori MV, Gardini S, Russo A, Del Chierico F, Putignani L. Clinical Parasitology and Parasitome Maps as Old and New Tools to Improve Clinical Microbiomics. Pathogens 2021;10:1550. [PMID: 34959505 DOI: 10.3390/pathogens10121550] [Reference Citation Analysis]
63 Du C, Luo Y, Walsh S, Grinspan A. Oral Fecal Microbiota Transplant Capsules Are Safe and Effective for Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2021;55:300-8. [PMID: 33471490 DOI: 10.1097/MCG.0000000000001495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
64 Ianiro G, Mullish BH, Kelly CR, Kassam Z, Kuijper EJ, Ng SC, Iqbal TH, Allegretti JR, Bibbò S, Sokol H, Zhang F, Fischer M, Costello SP, Keller JJ, Masucci L, van Prehn J, Quaranta G, Quraishi MN, Segal J, Kao D, Satokari R, Sanguinetti M, Tilg H, Gasbarrini A, Cammarota G. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut 2020;69:1555-63. [PMID: 32620549 DOI: 10.1136/gutjnl-2020-321829] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 27.5] [Reference Citation Analysis]
65 Kumar V, Fischer M. Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond. Expert Opin Biol Ther. 2020;20:73-81. [PMID: 31690143 DOI: 10.1080/14712598.2020.1689952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
66 Pérez-Matute P, Íñiguez M, de Toro M, Recio-Fernández E, Oteo JA. Autologous fecal transplantation from a lean state potentiates caloric restriction effects on body weight and adiposity in obese mice. Sci Rep 2020;10:9388. [PMID: 32523094 DOI: 10.1038/s41598-020-64961-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
67 Seo HS, Chin HS, Kim YH, Moon HS, Kim K, Nguyen LP, Yong D. Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank. Ann Lab Med 2021;41:424-8. [PMID: 33536363 DOI: 10.3343/alm.2021.41.4.424] [Reference Citation Analysis]
68 Park JC, Im SH. Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics. Exp Mol Med 2020;52:1383-96. [PMID: 32908211 DOI: 10.1038/s12276-020-0473-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
69 Coquant G, Aguanno D, Pham S, Grellier N, Thenet S, Carrière V, Grill JP, Seksik P. Gossip in the gut: Quorum sensing, a new player in the host-microbiota interactions. World J Gastroenterol 2021; 27(42): 7247-7270 [PMID: 34876787 DOI: 10.3748/wjg.v27.i42.7247] [Reference Citation Analysis]
70 Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021;116:1124-47. [PMID: 34003176 DOI: 10.14309/ajg.0000000000001278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Terra DAA, Vilela EG, Silva ROS, LeÃo LA, Lima KS, Passos RIFÂ, Diniz AN, Coelho LGV. STRUCTURING A FECAL MICROBIOTA TRANSPLANTATION CENTER IN A UNIVERSITY HOSPITAL IN BRAZIL. Arq Gastroenterol 2020;57:434-58. [PMID: 33331486 DOI: 10.1590/S0004-2803.202000000-79] [Reference Citation Analysis]
72 Mikail M, O'doherty KC, Poutanen SM, Hota SS. Ethical implications of recruiting universal stool donors for faecal microbiota transplantation. The Lancet Infectious Diseases 2020;20:e44-9. [DOI: 10.1016/s1473-3099(19)30569-9] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Scarpellini E, Ianiro G, Tack J. Editorial: Pharmacological Treatments Affecting Gastro-Intestinal Motility in Man. Front Pharmacol 2022;12:801136. [DOI: 10.3389/fphar.2021.801136] [Reference Citation Analysis]
74 Ajayi A, Jolaiya T, Smith S. Evolving Technologies in Gastrointestinal Microbiome Era and Their Potential Clinical Applications. J Clin Med 2020;9:E2565. [PMID: 32784731 DOI: 10.3390/jcm9082565] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Nakov R, Segal JP, Settanni CR, Bibbò S, Gasbarrini A, Cammarota G, Ianiro G. Microbiome: what intensivists should know. Minerva Anestesiol 2020;86:777-85. [PMID: 32368882 DOI: 10.23736/S0375-9393.20.14278-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
76 Hvas CL, Baunwall SMD, Erikstrup C. Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity. EClinicalMedicine 2020;24:100436. [PMID: 32642633 DOI: 10.1016/j.eclinm.2020.100436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Varga A, Kocsis B, Sipos D, Kása P, Vigvári S, Pál S, Dembrovszky F, Farkas K, Péterfi Z. How to Apply FMT More Effectively, Conveniently and Flexible - A Comparison of FMT Methods. Front Cell Infect Microbiol 2021;11:657320. [PMID: 34150673 DOI: 10.3389/fcimb.2021.657320] [Reference Citation Analysis]
78 Nicco C, Paule A, Konturek P, Edeas M. From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation. Diseases 2020;8:E9. [PMID: 32326509 DOI: 10.3390/diseases8020009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
79 Chi X, Pan CQ, Liu S, Cheng D, Cao Z, Xing H. Regulating Intestinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver Disease. Can J Gastroenterol Hepatol 2020;2020:6629196. [PMID: 33381475 DOI: 10.1155/2020/6629196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 Fujiwara H. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2021;12:703298. [PMID: 34512627 DOI: 10.3389/fimmu.2021.703298] [Reference Citation Analysis]
81 Ianiro G, Bibbò S, Masucci L, Quaranta G, Porcari S, Settanni CR, Lopetuso LR, Fantoni M, Sanguinetti M, Gasbarrini A, Cammarota G. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig Liver Dis 2020;52:1390-5. [PMID: 33004295 DOI: 10.1016/j.dld.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
82 Shaffer SR, Witt J, Targownik LE, Kao D, Lee C, Smieliauskas F, Rubin DT, Singh H, Bernstein CN. Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection. J Infect 2020;81:758-65. [PMID: 32980389 DOI: 10.1016/j.jinf.2020.09.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
83 Henig I, Yehudai-Ofir D, Zuckerman T. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Haematologica 2021;106:933-46. [PMID: 33241674 DOI: 10.3324/haematol.2020.247395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
84 Concas G, Barone M, Francavilla R, Cristofori F, Dargenio VN, Giorgio R, Dargenio C, Fanos V, Marcialis MA. Twelve Months with COVID-19: What Gastroenterologists Need to Know. Dig Dis Sci 2021. [PMID: 34333726 DOI: 10.1007/s10620-021-07158-0] [Reference Citation Analysis]
85 Khanna S, Pardi D. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era. Am J Gastroenterol 2020;115:971-4. [PMID: 32618640 DOI: 10.14309/ajg.0000000000000689] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
86 Karjalainen EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, Ristimäki A, Arkkila P, Lepistö AH. Fecal Microbiota Transplantation in Chronic Pouchitis: A Randomized, Parallel, Double-Blinded Clinical Trial. Inflamm Bowel Dis 2021:izab001. [PMID: 33501942 DOI: 10.1093/ibd/izab001] [Reference Citation Analysis]
87 Grigoryan Z, Shen MJ, Twardus SW, Beuttler MM, Chen LA, Bateman-House A. Fecal microbiota transplantation: Uses, questions, and ethics. Med Microecol 2020;6:100027. [PMID: 33834162 DOI: 10.1016/j.medmic.2020.100027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
88 Ianiro G, Bibbò S, Porcari S, Settanni CR, Giambò F, Curta AR, Quaranta G, Scaldaferri F, Masucci L, Sanguinetti M, Gasbarrini A, Cammarota G. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center. Gut Microbes 2021;13:1994834. [PMID: 34709989 DOI: 10.1080/19490976.2021.1994834] [Reference Citation Analysis]
89 Morkūnas E, Skiecevičienė J, Kupčinskas J. The impact of modulating the gastrointestinal microbiota in cancer patients. Best Pract Res Clin Gastroenterol 2020;48-49:101700. [PMID: 33317795 DOI: 10.1016/j.bpg.2020.101700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
90 Gerardin Y, Timberlake S, Allegretti JR, Smith MB, Kassam Z. Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome. J Infect Dis 2021;223:S276-82. [PMID: 33330910 DOI: 10.1093/infdis/jiaa700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Gill M, Blacketer C, Chitti F, Telfer K, Papanicolas L, Dann LM, Tucker EC, Bryant RV, Costello SP. Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank. JGH Open 2020;4:950-7. [PMID: 33102769 DOI: 10.1002/jgh3.12396] [Reference Citation Analysis]
92 Al-Bakri AG, Akour AA, Al-Delaimy WK. Knowledge, attitudes, ethical and social perspectives towards fecal microbiota transplantation (FMT) among Jordanian healthcare providers. BMC Med Ethics 2021;22:19. [PMID: 33639935 DOI: 10.1186/s12910-021-00587-6] [Reference Citation Analysis]
93 Park SH, Lee JH, Shin J, Kim JS, Cha B, Lee S, Kwon KS, Shin YW, Choi SH. Cognitive function improvement after fecal microbiota transplantation in Alzheimer's dementia patient: a case report. Curr Med Res Opin 2021;:1-6. [PMID: 34289768 DOI: 10.1080/03007995.2021.1957807] [Reference Citation Analysis]
94 Mullish BH, Quraishi MN, Segal JP, Ianiro G, Iqbal TH. The gut microbiome: what every gastroenterologist needs to know. Frontline Gastroenterol 2021;12:118-27. [PMID: 33613943 DOI: 10.1136/flgastro-2019-101376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
95 Yang YP, Zhang XY, Cui BT, Zhang H, Wu ZF, Tan X, Cheng W, Zhu X, Zhang FM, Qin HL, Wei H. Preclinical safety, effectiveness evaluation, and screening of functional bacteria for fecal microbiota transplantation based on germ-free animals. World J Meta-Anal 2021; 9(6): 496-504 [DOI: 10.13105/wjma.v9.i6.496] [Reference Citation Analysis]
96 Stojek M, Jabłońska A, Adrych K. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. J Clin Med 2021;10:4055. [PMID: 34575166 DOI: 10.3390/jcm10184055] [Reference Citation Analysis]
97 Yue B, Yu ZL, Lv C, Geng XL, Wang ZT, Dou W. Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease. World J Gastroenterol 2020; 26(30): 4378-4393 [PMID: 32874052 DOI: 10.3748/wjg.v26.i30.4378] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Vendrik KEW, Terveer EM, Kuijper EJ, Nooij S, Boeije-Koppenol E, Sanders IMJG, van Lingen E, Verspaget HW, Berssenbrugge EKL, Keller JJ, van Prehn J; Netherlands Donor Faeces Bank Study Group. Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study. Lancet Infect Dis 2021;21:711-21. [PMID: 33275940 DOI: 10.1016/S1473-3099(20)30473-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
99 Gesualdo M, Rizzi F, Bonetto S, Rizza S, Cravero F, Saracco GM, De Angelis CG. Pancreatic Diseases and Microbiota: A Literature Review and Future Perspectives. J Clin Med 2020;9:E3535. [PMID: 33139601 DOI: 10.3390/jcm9113535] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Reigadas E, van Prehn J, Falcone M, Fitzpatrick F, Vehreschild MJGT, Kuijper EJ, Bouza E; European Society of Clinical Microbiology and Infectious Diseases Study Group on Clostridioides difficile (ESGCD) and Study Group for Host and Microbiota interaction (ESGHAMI). How to: prophylactic interventions for prevention of Clostridioides difficile infection. Clin Microbiol Infect 2021:S1198-743X(21)00368-2. [PMID: 34245901 DOI: 10.1016/j.cmi.2021.06.037] [Reference Citation Analysis]
101 Kragsnaes MS, Kjeldsen J, Horn HC, Munk HL, Pedersen JK, Just SA, Ahlquist P, Pedersen FM, de Wit M, Möller S, Andersen V, Kristiansen K, Kinggaard Holm D, Holt HM, Christensen R, Ellingsen T. Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial. Ann Rheum Dis 2021;80:1158-67. [PMID: 33926922 DOI: 10.1136/annrheumdis-2020-219511] [Reference Citation Analysis]
102 Zatorski H, Nakov R. Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges. Curr Drug Targets 2020;21:1440-7. [PMID: 32484770 DOI: 10.2174/1389450121666200602125507] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Estevinho MM. Stools' donor recruitment, a challenge in pandemic times. United European Gastroenterol J 2021;9:993-4. [PMID: 34687164 DOI: 10.1002/ueg2.12168] [Reference Citation Analysis]
104 Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, Chen Y, Yin H, Wang H, Marcella C, Cui B, Cheng L, Ji G, Zhang F. Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell. 2020;11:251-266. [PMID: 31919742 DOI: 10.1007/s13238-019-00684-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
105 Liu Y, Alnababtah K, Cook S, Yu Y. Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review. Therap Adv Gastroenterol 2021;14:17562848211042679. [PMID: 34567271 DOI: 10.1177/17562848211042679] [Reference Citation Analysis]
106 Kao D, Wong K, Franz R, Cochrane K, Sherriff K, Chui L, Lloyd C, Roach B, Bai AD, Petrof EO, Allen-Vercoe E. The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial. Lancet Gastroenterol Hepatol 2021;6:282-91. [PMID: 33631102 DOI: 10.1016/S2468-1253(21)00007-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
107 Sandhu A, Chopra T. Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls. Therap Adv Gastroenterol 2021;14:17562848211053105. [PMID: 34992678 DOI: 10.1177/17562848211053105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Baunwall SMD, Dahlerup JF, Engberg JH, Erikstrup C, Helms M, Juel MA, Kjeldsen J, Nielsen HL, Nilsson AC, Rode AA, Vinter-Jensen L, Hvas CL. Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT). Scand J Gastroenterol 2021;56:1056-77. [PMID: 34261379 DOI: 10.1080/00365521.2021.1922749] [Reference Citation Analysis]
109 Ding X, Yang X, Wang H. Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease. Medicine in Microecology 2020;6:100028. [DOI: 10.1016/j.medmic.2020.100028] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Yalchin M, Segal JP, Mullish BH, Quraishi MN, Iqbal TH, Marchesi JR, Hart AL. Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease. Therap Adv Gastroenterol. 2019;12:1756284819891038. [PMID: 31803254 DOI: 10.1177/1756284819891038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
111 Mari A, Abu Baker F, Mahamid M, Sbeit W, Khoury T. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. J Clin Med 2020;9:E685. [PMID: 32143424 DOI: 10.3390/jcm9030685] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
112 Fecal Microbiota Transplantation-standardization Study Group. Nanjing consensus on methodology of washed microbiota transplantation. Chin Med J (Engl). 2020;. [PMID: 32701590 DOI: 10.1097/cm9.0000000000000954] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
113 Ashraf MF, Tageldin O, Nassar Y, Batool A. Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection: A Four-Year Single-Center Retrospective Review. Gastroenterology Res 2021;14:237-43. [PMID: 34527093 DOI: 10.14740/gr1436] [Reference Citation Analysis]
114 Aira A, Rubio E, Ruiz A, Vergara A, Casals-Pascual C, Rico V, Suñé-Negre JM, Soriano A. New Procedure to Maintain Fecal Microbiota in a Dry Matrix Ready to Encapsulate. Front Cell Infect Microbiol 2022;12:899257. [PMID: 35755849 DOI: 10.3389/fcimb.2022.899257] [Reference Citation Analysis]
115 Karjalainen EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, Ristimäki A, Arkkila P, Lepistö AH. Author's Reply: Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause? Inflamm Bowel Dis 2021;27:e79-80. [PMID: 33501940 DOI: 10.1093/ibd/izab003] [Reference Citation Analysis]
116 Cho YS. Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Clostridioides difficile Infection. Gut Liver 2021;15:1-2. [PMID: 33443235 DOI: 10.5009/gnl20368] [Reference Citation Analysis]
117 Wu S, Hugerth LW, Schuppe-koistinen I, Du J. The right bug in the right place: opportunities for bacterial vaginosis treatment. npj Biofilms Microbiomes 2022;8. [DOI: 10.1038/s41522-022-00295-y] [Reference Citation Analysis]
118 Zimmermann M, Patil KR, Typas A, Maier L. Towards a mechanistic understanding of reciprocal drug-microbiome interactions. Mol Syst Biol 2021;17:e10116. [PMID: 33734582 DOI: 10.15252/msb.202010116] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
119 Lee PC, Chang TE, Wang YP, Lee KC, Lin YT, Chiou JJ, Huang CW, Yang UC, Li FY, Huang HC, Wu CY, Huang YH, Hou MC. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. J Formos Med Assoc 2021:S0929-6646(21)00498-8. [PMID: 34836663 DOI: 10.1016/j.jfma.2021.11.001] [Reference Citation Analysis]
120 de Stefano MC, Mazzanti B, Vespasiano F, Lombardini L, Cardillo M. The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for Clostridioides difficile Infection in Italy. Antibiotics 2022;11:480. [DOI: 10.3390/antibiotics11040480] [Reference Citation Analysis]
121 Innes AJ, Mullish BH, Ghani R, Szydlo RM, Apperley JF, Olavarria E, Palanicawandar R, Kanfer EJ, Milojkovic D, McDonald JAK, Brannigan ET, Thursz MR, Williams HRT, Davies FJ, Marchesi JR, Pavlů J. Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation. Front Cell Infect Microbiol 2021;11:684659. [PMID: 34513724 DOI: 10.3389/fcimb.2021.684659] [Reference Citation Analysis]
122 Satokari R, Pietilä L, Mattila E, Lahtinen P, Arkkila PET. Faecal banking at -20 °C facilitates faecal microbiota transplantation for recurrent Clostridioides difficile infection in clinical practice. Infect Dis (Lond) 2020;52:662-5. [PMID: 32516025 DOI: 10.1080/23744235.2020.1774075] [Reference Citation Analysis]
123 Jo HG, Seo GS. [Efficacy and Safety of Fecal Microbiota Transplantation and Prospect of Microbe-based Therapies for Inflammatory Bowel Disease]. Korean J Gastroenterol 2021;78:31-6. [PMID: 34312355 DOI: 10.4166/kjg.2021.089] [Reference Citation Analysis]
124 Liu S, Zhao W, Lan P, Mou X. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell 2021;12:331-45. [PMID: 32601832 DOI: 10.1007/s13238-020-00745-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
125 AlQahtani H, Baloch S, Tabb D. Treatment of Recurrent Clostridium difficile Infection in an Immunocompromised Patient with Severe Neutropenia Not Responding to Standard Therapy. Case Rep Infect Dis 2020;2020:3089023. [PMID: 32158569 DOI: 10.1155/2020/3089023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Allegretti JR, Elliott RJ, Ladha A, Njenga M, Warren K, O'Brien K, Budree S, Osman M, Fischer M, Kelly CR, Kassam Z. Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation. Gut Microbes 2020;11:1806-8. [PMID: 32552337 DOI: 10.1080/19490976.2020.1768777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
127 Ribeiro CFA, Silveira GGOS, Cândido ES, Cardoso MH, Espínola Carvalho CM, Franco OL. Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health. ACS Infect Dis 2020;6:2544-59. [PMID: 32786282 DOI: 10.1021/acsinfecdis.0c00036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
128 Hurych J, Vejmelka J, Hlinakova L, Kramna L, Larionov V, Kulich M, Cinek O, Kohout P. Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors. BMJ Open 2022;12:e056594. [PMID: 35760542 DOI: 10.1136/bmjopen-2021-056594] [Reference Citation Analysis]
129 Aira A, Arajol C, Casals-Pascual C, González-Suárez B, Martí S, Domínguez MÁ, Guardiola J, Soriano Á; en representación del grupo catalán para el estudio y desarrollo de la transferencia de microbiota fecal. Recommendations for stool donor selection for fecal microbiota transplant. Consensus document endorsed by the Catalan Society of Digestology, Catalan Society of Infectious diseases and Clinical microbiology and the GEMBIOTA group from Spanish Society of Infectious Diseases and Clinical Microbiology. Enferm Infecc Microbiol Clin (Engl Ed) 2020:S0213-005X(20)30292-5. [PMID: 33160712 DOI: 10.1016/j.eimc.2020.09.002] [Reference Citation Analysis]
130 Cheng Y, Fischer M. Clinical management of severe, fulminant, and refractory Clostridioides difficile infection. Expert Review of Anti-infective Therapy 2020;18:323-33. [DOI: 10.1080/14787210.2020.1730814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Bilinski J, Dziurzynski M, Grzesiowski P, Podsiadly E, Stelmaszczyk-Emmel A, Dzieciatkowski T, Dziewit L, Basak GW. Multimodal Approach to Assessment of Fecal Microbiota Donors based on Three Complementary Methods. J Clin Med 2020;9:E2036. [PMID: 32610522 DOI: 10.3390/jcm9072036] [Reference Citation Analysis]
132 Craven LJ, Parvathy SN, Burton JP, Silverman MS. Response to Ianiro et al. Am J Gastroenterol 2021;116:1361-2. [PMID: 34074837 DOI: 10.14309/ajg.0000000000001160] [Reference Citation Analysis]
133 Zhu F, Ke Y, Luo Y, Wu J, Wu P, Ma F, Liu Y. Effects of Different Treatment of Fecal Microbiota Transplantation Techniques on Treatment of Ulcerative Colitis in Rats. Front Microbiol 2021;12:683234. [PMID: 34335508 DOI: 10.3389/fmicb.2021.683234] [Reference Citation Analysis]
134 Clancy AK, Lee C, Hamblin H, Gunaratne AW, LeBusque A, Beck EJ, Dawson MV, Borody TJ. Dietary Intakes of Recipients of Faecal Microbiota Transplantation: An Observational Pilot Study. Nutrients 2021;13:1487. [PMID: 33924834 DOI: 10.3390/nu13051487] [Reference Citation Analysis]
135 Speri E, Janardhanan J, Masitas C, Schroeder VA, Lastochkin E, Wolter WR, Fisher JF, Mobashery S, Chang M. Discovery of a Potent Picolinamide Antibacterial Active against Clostridioides difficile. ACS Infect Dis 2020;6:2362-8. [PMID: 32786277 DOI: 10.1021/acsinfecdis.0c00479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
136 Adamkova P, Hradicka P, Gancarcikova S, Kassayova M, Ambro L, Bertkova I, Maronek M, Farkasova Iannaccone S, Demeckova V. Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. Pathogens 2021;10:152. [PMID: 33540919 DOI: 10.3390/pathogens10020152] [Reference Citation Analysis]
137 Bibbò S, Ianiro G, Giambò F, Settanni CR, Cammarota G, Gasbarrini A. Role of gut microbiome on immunotherapy efficacy in melanoma. Hum Vaccin Immunother 2021;:1-6. [PMID: 34190675 DOI: 10.1080/21645515.2021.1926759] [Reference Citation Analysis]
138 Hyde MK, Masser BM. Determinants of community members' willingness to donate stool for faecal microbiota transplantation. PLoS One 2020;15:e0243751. [PMID: 33301497 DOI: 10.1371/journal.pone.0243751] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Sarbagili Shabat C, Scaldaferri F, Zittan E, Hirsch A, Mentella MC, Musca T, Cohen NA, Ron Y, Fliss Isakov N, Pfeffer J, Yaakov M, Fanali C, Turchini L, Masucci L, Quaranta G, Kolonimos N, Godneva A, Weinberger A, Kopylov U, Levine A, Maharshak N. Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial. J Crohns Colitis 2021:jjab165. [PMID: 34514495 DOI: 10.1093/ecco-jcc/jjab165] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Núñez F P, Quera R, Bay C, Thomson P. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. Gastroenterol Hepatol 2021:S0210-5705(21)00192-8. [PMID: 34118321 DOI: 10.1016/j.gastrohep.2021.05.009] [Reference Citation Analysis]
141 Merrick B, Allen L, Masirah M Zain N, Forbes B, Shawcross DL, Goldenberg SD. Regulation, risk and safety of Faecal Microbiota Transplant. Infect Prev Pract 2020;2:100069. [PMID: 34316559 DOI: 10.1016/j.infpip.2020.100069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
142 Ianiro G, Porcari S, Bibbò S, Giambò F, Quaranta G, Masucci L, Sanguinetti M, Gasbarrini A, Cammarota G. Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank. Dig Liver Dis 2021:S1590-8658(21)00195-X. [PMID: 34030988 DOI: 10.1016/j.dld.2021.04.009] [Reference Citation Analysis]
143 Gupta S, Mullish BH, Allegretti JR. Fecal Microbiota Transplantation: The Evolving Risk Landscape. Am J Gastroenterol 2021;116:647-56. [PMID: 33982930 DOI: 10.14309/ajg.0000000000001075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
144 Benech N, Sokol H. Expert centres for faecal microbiota transplantation: The guarantee for safe and effective use of faecal transplants. United European Gastroenterol J 2020;8:1145-6. [PMID: 33167783 DOI: 10.1177/2050640620970372] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Ahmed E, Hens K. Microbiome in Precision Psychiatry: An Overview of the Ethical Challenges Regarding Microbiome Big Data and Microbiome-Based Interventions. AJOB Neurosci 2021;:1-17. [PMID: 34379050 DOI: 10.1080/21507740.2021.1958096] [Reference Citation Analysis]
146 Ding L, He C, Li X, Huang X, Lei Y, Ke H, Chen H, Yang Q, Cai Y, Liao Y, He W, Xia L, Xiong H, Lu N, Zhu Y. Efficacy and Safety of Faecal Microbiota Transplantation for Acute Pancreatitis: A Randomised, Controlled Study. Front Med (Lausanne) 2021;8:772454. [PMID: 35083238 DOI: 10.3389/fmed.2021.772454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Kousgaard SJ, Michaelsen TY, Nielsen HL, Kirk KF, Brandt J, Albertsen M, Thorlacius-Ussing O. Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis: a pilot study. Scand J Gastroenterol 2020;55:421-9. [PMID: 32285709 DOI: 10.1080/00365521.2020.1748221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
148 Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, Pugliese D, Neri M, Cammarota G, Ringel Y, Costamagna G, Gasbarrini A, Boskoski I, Armuzzi A. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020;26:1306-1314. [PMID: 32720978 DOI: 10.1093/ibd/izaa181] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]